WeVote

Bill

Bill

SB 758

AN ACT CONCERNING PHARMACY BENEFITS MANAGER REFORM.

2025 Regular Session Introduced by Saud Anwar and 1 co-sponsor

Connecticut proposes pharmacy benefits manager regulations to increase pricing transparency and limit practices that drive up medication costs and restrict pharmacy access.

REF. TO JOINT COMM. ON Insurance and Real Estate
0
WeVote Research Nonpartisan
Bill Summary · SB 758

Legislative bill overview

SB 758 proposes regulatory reforms to Connecticut's pharmacy benefits manager (PBM) industry, which intermediates between insurers, pharmacies, and drug manufacturers. The bill aims to increase transparency and potentially limit certain PBM practices that have drawn criticism for increasing medication costs and limiting patient access to pharmacies.

Why is this important

PBMs significantly influence drug pricing and pharmacy network access for Connecticut residents, yet operate with minimal state oversight. Reform could lower medication costs for consumers, improve pharmacy profit margins, and increase competition—or conversely, could reduce PBM operational efficiency and drug availability if reforms are too restrictive.

Potential points of contention

  • Transparency mandates vs. trade secrets: Requiring PBMs to disclose pricing algorithms and negotiation practices may conflict with claims of proprietary business information
  • Pass-through costs: Regulations limiting PBM spread (the difference between what they pay pharmacies and charge insurers) could reduce their business model viability or be passed to consumers through higher premiums
  • Network adequacy: Rules restricting which pharmacies PBMs can exclude from networks may increase costs but ensure patient access, creating tradeoffs between affordability and choice
  • Implementation timeline: Unclear if the bill specifies enforcement mechanisms or compliance deadlines for existing PBM contracts

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.